Spectrum’s Autism Drug Trial Tracker provides interactive, curated information about hundreds of clinical trials for autism and related conditions.
Spectrum: Autism Research News
Articles by "SpectrumAdmin"
As 2021 comes to a close, Spectrum recaps some of the biggest trends in autism science this year: studies of sex differences, noncoding regions of the genome and points of convergence, as well as efforts to improve screening and participatory research.
Is autism really more common among children today than in generations past? This new downloadable book offers an in-depth guide to the various factors that have helped to drive autism prevalence numbers up.
This week’s Community Newsletter brings you conversations around new autism prevalence numbers in the United States and United Kingdom, and David Mandell’s departure as editor-in-chief of Autism.
Cannabis-derived drugs are approved to treat only a small number of autism-related conditions, but many autistic people and their families experiment with medical marijuana to ease autism traits. In this special report, Spectrum rounds up what the science says about cannabis and autism.
In this week’s Community Newsletter, we highlight online conversations about the conference’s technology foibles and scientific tours de force.
In the past two decades, some autism researchers have turned to simple animals, such as roundworms, fruit flies and zebrafish, for their investigations. Others have sought answers from experiments with frogs, birds and even octopuses.
This week’s Twitter stroll turns up papers on autism’s genetic architecture, news affecting the burgeoning gene synthesis industry, and a new festival focused on participatory research.
Social difficulties. Restricted and repetitive patterns of behavior. Sensory sensitivity. Autism has long been defined by its challenges But autism sometimes comes with advantages. This special report highlights those advantages and describes the research behind them.